世界のALK陽性肺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5075
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ALK陽性肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリゾチニブ、アレクチニブ、セリチニブ、ブリグチニブ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ALK陽性肺がん治療の市場動向
・企業の競争状況、市場シェア
・ALK陽性肺がん治療の種類別市場規模と予測2016-2027（クリゾチニブ、アレクチニブ、セリチニブ、ブリグチニブ、その他）
・ALK陽性肺がん治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・ALK陽性肺がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・ALK陽性肺がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ALK陽性肺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ALK陽性肺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ALK陽性肺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche、Pfizer、Novartis、TP Therapeutics、Bristol-Myers Squibb、Eli Lilly and Company、Takeda、Beacon Pharma）
・結論

ALK positive lung cancer treatment treats people get lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene).

Market Analysis and Insights: Global ALK Positive Lung Cancer Treatment Market
The global ALK Positive Lung Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ALK Positive Lung Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ALK Positive Lung Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ALK Positive Lung Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ALK Positive Lung Cancer Treatment market.

Global ALK Positive Lung Cancer Treatment Scope and Market Size
ALK Positive Lung Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ALK Positive Lung Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Other

Segment by Application
Hospital
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Other
1.3 Market by Application
1.3.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2016-2027)
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ALK Positive Lung Cancer Treatment Industry Dynamic
2.3.1 ALK Positive Lung Cancer Treatment Market Trends
2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
2.3.4 ALK Positive Lung Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue
3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2020
3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2016-2027)
6.2 North America ALK Positive Lung Cancer Treatment Market Size by Type
6.2.1 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Application
6.3.1 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country
6.4.1 North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2016-2027)
7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type
7.2.1 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application
7.3.1 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country
7.4.1 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2016-2027)
9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type
9.2.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application
9.3.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America ALK Positive Lung Cancer Treatment Market Size by Country
9.4.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 TP Therapeutics
11.4.1 TP Therapeutics Company Details
11.4.2 TP Therapeutics Business Overview
11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.4.5 TP Therapeutics Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.6.5 Eli Lilly and Company Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Beacon Pharma
11.8.1 Beacon Pharma Company Details
11.8.2 Beacon Pharma Business Overview
11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.8.5 Beacon Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Other
Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027)
Table 13. ALK Positive Lung Cancer Treatment Market Trends
Table 14. ALK Positive Lung Cancer Treatment Market Drivers
Table 15. ALK Positive Lung Cancer Treatment Market Challenges
Table 16. ALK Positive Lung Cancer Treatment Market Restraints
Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020)
Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 67. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer ALK Positive Lung Cancer Treatment Product
Table 72. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis ALK Positive Lung Cancer Treatment Product
Table 77. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. TP Therapeutics Company Details
Table 80. TP Therapeutics Business Overview
Table 81. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 82. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. TP Therapeutics Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 87. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Eli Lilly and Company Company Details
Table 90. Eli Lilly and Company Business Overview
Table 91. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 92. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Eli Lilly and Company Recent Development
Table 94. Takeda Company Details
Table 95. Takeda Business Overview
Table 96. Takeda ALK Positive Lung Cancer Treatment Product
Table 97. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. Takeda Recent Development
Table 99. Beacon Pharma Company Details
Table 100. Beacon Pharma Business Overview
Table 101. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. Beacon Pharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Crizotinib Features
Figure 3. Alectinib Features
Figure 4. Ceritinib Features
Figure 5. Brigatinib Features
Figure 6. Other Features
Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 12. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2020
Figure 19. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 63. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 67. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の肺がん治療市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4445 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、標的療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4443 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4444 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法、化学療法、放射線療法、その他）、用途別市場規模（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC））、主要地域別市場...

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4446 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年）

Global Solid Tumor Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4884 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、固形腫瘍がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、免疫療法、ホルモン療法、外科的処置）、用途別市場規模（乳がん、子宮頸がん、結腸直腸がん、肺がん、前立腺がん、その他）...

世界のがんゲノム検査市場規模・現状・予測（2021年-2027年）

Global Cancer Genomic Testing Market Size, Status and Forecast 2021-2027
QFJ1-3954 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、がんゲノム検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳がんゲノム検査、肺がんゲノム検査、血液がんゲノム検査、肝臓がんゲノム検査、胃がんゲノム検査、その他）、用途別市場規模（病院、診療所、診断...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年） Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD.Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Market Analysis and Insights: Global Lung Pulmonary Airway Disease…